The discussion will be broadcast live via the company’s investor relations portal, where an archived version will remain accessible following the conclusion of the event. Shoulder Innovations, which trades under the ticker SI on the NYSE, currently focuses on advanced implant systems for arthroplasty designed to streamline preoperative planning and procedural workflows.

Beyond hardware, the company promotes an integrated ecosystem that combines surgical enabling technologies with specialized instrument systems. By emphasizing surgeon-to-surgeon collaboration and clinical simplicity, the firm aims to address persistent inefficiencies within the care chain. This appearance comes as the company continues its commercial-stage expansion, seeking to standardize outcomes across various clinical sites.